However, this observation is not consistent with those of previous studies where the HER-2 positivity rate of early-stage cancers was lower than that of advanced-stage tumors (16,33), or where the HER-2 positivity rate of cancers was shown not be associated with the TNM stage (12,20,24,26,34). This evidence concerns the gene ERBB2 and cancer.